What systemic therapy option do you use for metastatic, anal squamous cancer with progression following FOLFOX and subsequent nivolumab?

1 Answers

Mednet Member

Medical Oncology · University of Texas MD Anderson Cancer Center

If a clinical trial is not available and residual neuropathy from oxaliplatin is not an issue, I would favor carboplatin/paclitaxel.